Agilon Health (NYSE:AGL – Get Free Report) announced its earnings results on Wednesday. The company reported $1.97 EPS for the quarter, beating the consensus estimate of ($1.23) by $3.20, FiscalAI reports. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The company had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.46 billion.
Agilon Health Price Performance
NYSE:AGL traded up $7.83 during mid-day trading on Wednesday, hitting $95.62. 277,309 shares of the stock traded hands, compared to its average volume of 319,459. The business’s 50-day moving average price is $87.43 and its 200 day moving average price is $65.50. The company has a market cap of $1.61 billion, a PE ratio of -6.70 and a beta of 3.10. Agilon Health has a 12-month low of $7.48 and a 12-month high of $133.04. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on AGL shares. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a report on Monday, August 24th. Truist Financial set a $112.00 price objective on shares of Agilon Health and gave the company a “hold” rating in a research note on Thursday, August 6th. Royal Bank Of Canada set a $125.00 target price on shares of Agilon Health in a research report on Tuesday, September 15th. Wells Fargo & Company reissued an “overweight” rating and set a $146.00 target price (up from $141.00) on shares of Agilon Health in a research report on Tuesday, August 11th. Finally, Benchmark restated a “buy” rating and issued a $140.00 target price (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Six equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Agilon Health has an average rating of “Hold” and a consensus price target of $102.25.
Get Our Latest Stock Analysis on Agilon Health
About Agilon Health
Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company works with physician practices serving primarily older adults enrolled in Medicare Advantage and helps them manage the cost, quality and coordination of care for their patient populations.
Agilon provides a technology-enabled platform that includes population health analytics, clinical and administrative support, care coordination resources and practice-management capabilities.
Read More
- Five stocks we like better than Agilon Health
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
